throbber
Eur. J. Biochem. 2/9, 727-736 (1994)
`© FEBS 1994
`
`Characterization and partial purification of the human receptor
`for the heat-stable enterotoxin
`
`Sandhya S. VISWESWARIAH, Vasanthi RAMACHANDRAN,Surabhi RAMAMOHAN,Goutam DASand Janakiraman RAMACHANDRAN
`
`Astra Research Centre, Malleswaram, Bangalore, India
`
`(Received August 2/October 20, 1993) ~- EJB 93 1152/1
`
`The receptor for the Escherichia coli heat-stable enterotoxin has been characterized and partially
`purified from the T84 humancolonic cell line. Using a novel mutant heat-stable enterotoxin peptide
`as a radioligand (the C-terminal tyrosine residue is replaced by phenylalanine in the mutant), a
`single class of high-affinity receptor sites was detected in T84 cells, with a K, of 0.1 nM, similar in
`affinity to the receptor described in human intestinal tissue. The receptor was solubilised from T84
`cell membranes andaffinity cross-linking of the solubilised preparation indicated that a single spe-
`cies of M, 160000 served as the receptor. Freshly solubilised preparations of the receptor retained
`heat-stable enterotoxin-activable guanylyl cyclase activity. Purification of the receptor was achieved
`through sequential affinity chromatography on GTP~epoxy-Sepharose and wheat-germ-agglutinin
`columns resulting in purification of the receptor by 3000 fold. The heat-stable enterotoxin-binding
`characteristics of the receptor were unchanged during the purification and silver staining of the
`purified receptor preparation indicated a band of M, 160000, which wasspecifically cross-linked to
`the '*°I-labeled mutant peptide. The purified receptor retained guanylyl cyclase activity, but the
`activity was not stimulated on addition of human heat-stable enterotoxin, suggesting that accessory
`structural factors may be involved in the activation of the guanylyl cyclase/receptor.
`
`The heat-stable enterotoxins (ST) are a family of low-
`molecular-mass peptide toxins, and are one of the major
`causes of watery secretory diarrhoea all over the world [1,
`2}. Various forms of the toxins, differing in amino acid se-
`quence, are produced by a number of pathogenic bacteria (3,
`4], and all these peptides contain a cysteine-rich core essen-
`tial for full biological activity [5, 6]. ST peptides bind to
`a receptor on intestinal cells and activate membrane-bound
`guanylyl cyclase [7, 8]. Increased levels of cyclic GMP
`(cGMP) within the cell are hypothesised to lead to enhanced
`Cl secretion from the intestinal cell by as yet undefined
`mechanisms, resulting in fluid loss and subsequent diarrhoea
`[9].
`
`Early biochemical studies had postulated that in rat intes-
`tinal membranes the ST-binding and guanylyl cyclase activi-
`ties were located on separate molecules [10]. However, the
`cloning and expression of the rat and human intestinal ST
`receptor [11-13] suggested that the ST receptor wasin fact
`a high-molecular-mass protein and a memberof the guanylyl
`cyclase family of receptors, described earlier for atrial natri-
`uretic factor and the sea urchin egg peptides [14]. These ob-
`servations implied that the ST-binding and guanylyl cyclase
`activities were present in the same receptor molecule. How-
`Correspondence to S. S. Visweswariah, Astra Research Centre,
`India, P. O. Box 359, Malleswaram, Bangalore, India 560 003
`Fax: +91 80 3340449.
`Abbreviations. cGMP, cyclic GMP; ST, heat-stable entero-
`toxin(s); ST,, human heat-stable enterotoxin(s); ST,, porcine heat-
`stable enterotoxin; ST Y72F,heat-stable enterotoxin with C-terminal
`tyrosine residue replaced by phenylalanine.
`Enzyme. Guanylyl cyclase (EC 4.6.1.2).
`
`ever, there is no biochemical evidence using purified receptor
`preparations to confirm that the ST receptor does in fact exist
`in the cell as suggested for the recombinant protein. Hugues
`et al. reported the purification of the rat ST receptor from
`intestinal membranes using ST—ligand affinity chromatogra-
`phy and suggested that a protein of M, 70000 was the recep-
`tor [15]. However, the purified protein did not possess gua-
`nylyl cyclase activity, and this was attributed to the instability
`of the guanylyl cyclase activity from rat intestinal mem-
`branes during purification procedures. However, the major
`protein purified in these studies was of a lower molecular
`mass than that predicted from the DNA sequence of the
`cloned receptor and hence may not have represented the
`functional ST receptor [15].
`Earlier studies from this laboratory have demonstrated
`[17] that application of ST and other forms of ST peptides,
`produced by a variety of bacteria, to T84 cells, a cell line
`derived from a human colonic carcinoma [18], resulted in
`enhanced cGMPproduction bythe cells, strongly suggesting
`that these peptides all bind to the same receptor. Interestingly,
`the response of T84 cells to various analogues of ST led to
`the differential production of cGMP [19], suggesting altered
`interaction of the ST peptides with the human receptor on
`T84 cells. The T84 cell line thus served as a model system
`to study ST/human receptor interactions in detail. In this
`study, the characterization and purification of the ST receptor
`from T84 cells are described. We report the partial purifica-
`tion of a high-molecular-mass protein that retains both ST-
`binding and guanyly} cyclase activities, and presumably acts
`as a functional ST receptor.
`
`MSN Exhibit 1032 - Page 1 of 10
`MSNv. Bausch - IPR2023-00016
`
`

`

`728
`
`MATERIALS AND METHODS
`
`Culture and maintenance of T84 cells
`
`T84 cells were cultured and maintained as described
`earlier
`[18]. Cells were either grown in 24-well dishes
`(Nunc) to a density of 5X10° cells/well, at which time they
`were used directly for monitoring the activation of guanylyl
`cyclase by ST [19], or grown to confluency in bottles and
`harvested for the preparation of membranes.
`
`Production of mutant ST peptide
`
`Mutagenesis was performed on the cloned ST gene [16],
`essentially according to the method of Kunkel [20]. The se-
`quence of the mutagenic primer was 5’ CCGGGTGCTTTT-
`AATAATAT3’, and the sequence of the product mutant
`gene was confirmed by DNA sequencing [21]. The mutant
`gene wascloned into the pET7 vector as a BamHI—Hindlll
`fragment to yield the vector pARC 0730, which was trans-
`formed into the strain BL21 (DE3) as described earlier [16].
`The mutant ST peptide was overexpressed under identical
`conditions described for the human heat-stable enterotoxin
`(ST,) gene [16].
`
`Purification of ST,, and mutant ST peptide
`from the culture fluid of the overexpressing strains
`
`ST,, peptide was purified according to the method re-
`ported earlier [16]. The purification procedure for the ST
`Y72F mutant peptide (tyrosine at position 72 is replaced by
`phenylalanine) was similar to that employed for ST,, except
`for a few modifications. Following adsorption of the peptide
`to Amberlite XAD-2, elution and concentration by lyophili-
`sation of the bound peptide, ST Y72F was purified by re-
`verse-phase HPLC, using an Applied Biosystems 150 series
`HPLC system on an Aquapore RP 300 column (7-um particle
`size, 220 mmX4.6 mm, Applied Biosystems). Gradient elu-
`tion of the bound peptide was achieved using a gradient of
`20—100% B over 30 min at a flow rate of 1 ml/min. Buffer
`A consisted of 0.05% trifluoroacetic acid in water, and buffer
`B consisted of 70% acetonitrile in 0.05 % trifluoroacetic acid/
`water. ST Y72F peptide was eluted with a retention time of
`16-17 min in this gradient. Both ST, and ST Y72F were
`purified again through the gradient system described above
`to ensure homogeneity of the preparations.
`Peptides were quantified by amino acid analysis [22], and
`the analysis confirmed the sequence of the two peptides.
`
`Radio-iodination of ST Y72F and purification
`of the radiolabelled peptide
`Purified ST Y72F was radiolabelled with carrier-free
`Na‘*°I (ICN Radiochemicals) by the lactoperoxidase method.
`Lactoperoxidase beads (BioRad) were reacted with 5 pg ST
`Y72F and 1 mCi carrier-free Na’in 50 pl 100 mM sodium
`phosphate, pH 7.5, containing 40 pg of f-p-glucose, at 4°C
`for 1h. The reaction mixture was applied to a Sep-Pak car-
`tridge (Millipore) previously equilibrated with water. The
`cartridge was washed with water to remove free Na’™I and
`the bound peptide was eluted with 50% acetonitrile in water.
`The fractions containing radiolabelled peptide were concen-
`trated to remove the acetonitrile, and subjected to reverse-
`phase HPLC to purify the radiolabelled peptide. Reverse-
`phase HPLC was performed on a wBondapak C,, (column
`4-um particle size, 2 mm*X30 mm, Waters Associates). The
`
`radiolabelled peptide was eluted using a gradient from 10%
`acetonitrile in water to 30% acetonitrile in water in 90 min
`at a flow rate of 0.3 ml/min. Fractions were collected every
`2 min, and the radiolabelled peptide eluted with a retention
`time of 70—75 min in this gradient. Under identical condi-
`tions, unlabelled ST Y72F eluted with a retention time of
`60-65 min. The specific activity of the radiolabelled ST
`Y72F was 2000Ci/mmol, equivalent to the specific activity
`of the Na’. Radiolabelled ST Y72F was stored at 4°C in
`the presence of 20% acetonitrile, under which conditionsit
`was stable for more than a month.
`
`Guanylyl cyclase assays on T84 monolayers
`Assays were performed as described earlier [19]. Pep-
`tides were added in serum-free media and intracellular cGMP
`was measured by radioimmunoassay after 15 min following
`application of the toxin. Radioimmunoassay was performed
`using '*°I-labelled cGMPas reported earlier [19]. All cGMP
`levels were measured without acetylation of either the sam-
`ple or the standards.
`
`Preparation of T84 membranes
`Confluent monolayers of T84 cells were harvested by
`scraping into 50mM Hepes, pH 7.5, containing 0.25M
`sucrose, 1 g/ml leupeptin, 1 g/ml aprotinin, 2 mM phenyl-
`methylsuiphonyl fluoride, 100 mM NaCl, 1 mM dithiothrei-
`tol and 5 mM EDTA (108 cells/10 ml buffer). Cells were ho-
`mogenised in this buffer and the broken cell suspension was
`subjected to centrifugation at 100000 g for 1h. The mem-
`brane pellet thus obtained was suspended at a concentration
`of 5—10 mg protein/ml in 50 mM Hepes, pH 7.5, 10 pg/ml
`leupeptin and 10 g/ml aprotinin. Protein was estimated by
`the method of Bradford [23].
`
`In vitro activation of guanylyl cyclase
`In vitro guanylyl cyclase assays were performed essen-
`tially according to Hugueset al. [15]. T84 membranefrac-
`tions, or solubilised or purified preparations of the ST recep-
`tor, were suspended in 60 mM Tris/HCl, pH. 7.6, containing
`10 mM theophylline, 7.5 mM creatine phosphate, and 20 pg
`creatine phosphokinase. ST peptides, at the indicated concen-
`trations were added to the mixture, and the assay wasiniti-
`ated by addition of a Mg-GTPsolution to a final concentra-
`tion of 1 mM GTP and 4mM MgCl. The assay mixture
`(final volume 100 11) was incubated at 37°C for 10 min and
`the reaction was stopped by the addition of 0.4 ml 50 mM
`sodium acetate, pH 4.0, and boiling of the reaction mixture
`for 10 min. Samples were centrifuged at 10000 g for 10 min
`and analysed for cGMPby radioimmunoassay. For monitor-
`ing guanylyl cyclase activity following the binding of ST to
`T84 membranes at different pH, ST, (1 WM) was added to
`membrane preparations at the pH indicated, and the incuba-
`tion was continued at 37°C for 10 min. Samples werecentri-
`fuged, the membranes suspended in buffer containing com-
`ponents for the in vitro guanylyl cyclase assay and the assay
`wasstarted by the addition of Mg-GTP. The assay wasper-
`formed at 37°C for 10 min and cGMP was measured as
`described above.
`
`Binding assays
`Binding to T84 membranes was performed using 20—
`50 ug T84 membrane protein,
`in 50mM Hepes, pH 7.5,
`
`MSN Exhibit 1032 - Page 2 of 10
`MSNv. Bausch - IPR2023-00016
`
`

`

`4mM MgCl, 0.1% bovine serum albumin, and 10 pg/ml
`leupeptin, at 37°C for 60 min. The total assay volume was
`100 jl and contained 0.1 nM **J-labelled ST Y72F. Non-spe-
`cific binding was determined in the presence of unlabelled
`ST Y72F, ST,,, or atrial natriuretic factor. Following incuba-
`tion, samples were filtered through GF/B filters (Whatman)
`and washed three times with 3 ml chilled 10mM sodium
`phosphate, pH 7.2, containing 0.9% NaCl and 0.2% bovine
`serum albumin. Filters were measured for radioactivity using
`a scintillation counter (LKB Clini Gamma).
`Binding assays at different pH were performed in either
`50 mM sodium acetate, pH 5.0, or 100 mM sodium carbon-
`ate/sodium bicarbonate buffer, pH 10.7. Washing of the fil-
`ters was performed as above.
`Binding assays to solubilised preparations of the receptor
`or purified fractions were performed under identical condi-
`tions in a total volume of 100 yl. However, the separation of
`bound ligand from free peptide was through precipitation
`using poly(ethylene glycol) 6000. Following binding, 200
`30% poly(ethylene glycol) in 50 mM Tris/HCl, 1 mM EDTA,
`pH 7.5, and 20 ul 3 mg/ml bovine immunoglobulin G was
`added to the samples and they were incubated at 4°C for
`10 min. Samples were filtered through GF/B filters pre-
`viously soaked in 0.2% bovine serum albumin, and filters
`were washedthrice with 3 ml chilled 10% poly(ethylene gly-
`col) in 50 mM Tris/HCl, pH 7.5, containing 1mM EDTA.
`Filters were dried and the radioactivity was measured as be-
`fore.
`In all binding assays, non-specific binding contributed to
`less than 10% of the total binding observed. Equilibrium
`binding data were analysed by the LUNDON 1 programme
`supplied by LUNDONSoftware Inc.
`
`Association and dissociation kinetics for the binding
`of '*I-labelled ST Y72F
`
`Association kinetics of '*°I-labelled ST Y72F were deter-
`mined at an ST Y72F concentration of 0.1 nM in the pres-
`ence or absence of 100 nM unlabelled ST Y72F. Binding was
`performed as described above and aliquots of the reaction
`mixture were removedat the times indicated andfiltered. For
`dissociation experiments, membranes were incubated with
`25]-labelled ST Y72F (1 nM)for 1 h followed by centrifuga-
`tion at 25000 g for 10 min at 4°C. Membranes were sus-
`pended in the original binding buffer in the absence of la-
`belled ligand. Aliquots were removed at the times indicated
`and samples werefiltered. The kinetic data for ligand associ-
`ation and dissociation were subjected to the analysis of Wei-
`land and Molinoff
`[24]. The dissociation rate constant
`(k_,) was determined directly from a first-order plot of ligand
`dissociation versus time. The rate of ligand association (k,)
`was determined from the. equation k, =k. (ILR]./{(L]
`[LR]max}), where [L] is the ligand concentration, [LR], is the
`concentration of the complex at equilibrium, [LR]. is the
`maximum number of receptors present and k,,, is the slope
`of the pseudo-first-order plot of In ((LR]./{{LR].—[LR].})
`versus time.
`
`Solubilisation and cross-linking or the ST receptor
`from T84 membranes
`
`T84 membrane suspensions (5 mg/ml) were adjusted to
`0.3% Lubrol PX (Sigma) and 0.5 M NaCl. The suspension
`was gently homogenised and kept stirring at 4°C for 1 h. The
`
`729
`
`sample was centrifuged at 100000 g for 1 h and the superna-
`tant was used as the soluble receptor preparation.
`For cross-linking of '**I-labelled ST Y72Fto the receptor,
`100 ug solubilised receptor preparation was incubated with
`1 nM **I-labelled ST Y72F,either in the presence or absence
`of 100 nM unlabelled ST,,, at 37°C for 1h. The cross-linker
`dithiobis-(succinimidyl propionate), obtained from Pierce,
`was added to a concentration of 2 mM in a minimal volume
`of dimethyl sulphoxide, and the incubation was continued
`at 25°C for 30 min. Samples were subjected to SDS/PAGE
`according to the method of Laemmli [25]. Samples were
`boiled either in the presence or absence of 2-mercaptoethanol
`and electrophoresed in 7.5% acrylamide gels. Following
`electrophoresis, the gels were dried and subjected to autora-
`diography.
`
`Affinity cross-linking of the ST receptor
`from humanintestinal tissue
`
`Biopsy tissue from regions of the human small intestine
`were obtained from a local hospital, and scrapings of the
`mucosal membranetissue were prepared. The scrapings were
`suspended in 50 mM Hepes, pH 7.5, containing 1 pg/ml leu-
`peptin, 100 mM NaCl and 2 mM dithiothreitol and homogen-
`ised. The suspension was centrifuged at 100000 g for 30 min,
`and the membrane fraction suspended in 50 mM Hepes,
`pH 7.5, containing 10 pg/ml leupeptin, 10 pg/ml aprotinin
`and 4 mM MgCl, to a concentration of 20 mg membranepro-
`tein/ml. The suspension was adjusted to 0.3% Lubrol PX and
`0.5 M NaCl, and stirred at 4°C for 1h. The supernatant of
`this suspension, obtained after centrifugation at 100000 g for
`1h, was used for cross-linking analysis in an identical man-
`ner to that employed for the T84 cells, except that 500 ug
`total protein was used for cross-linking.
`
`Purification of the ST receptor from T84 cells
`
`Solubilised receptor preparations were dialysed against
`50 mM Hepes, pH 7.5, containing 0.1% Lubrol PX, 2 mM
`NaN;, 4mM MgCl,, 1 pg/ml leupeptin,
`1 pg/ml aprotinin
`and 20% glycerol. Removal of NaCl in the solubilised prepa-
`rations was essential prior to subjecting the preparation to
`GTP—epoxy-Sepharose affinity chromatography. The GTP—
`epoxy-Sepharose affinity matrix was prepared by coupling
`GTP to epoxy-activated Sepharose (Pharmacia) following the
`manufacturer’s instructions, which resulted in the coupling
`of 8-15 mol GTP/ml agarose. The dialysed receptor prepa-
`ration was mixed gently with the affinity matrix at 4°C for
`16h after which the beads were washed with the dialysis
`buffer to remove unboundproteins. The receptor was eluted
`with the same buffer without MgCl, but containing 10 mM
`EDTA.Fractions were collected and tested for their ability to
`bind radioactive ST Y72F. Fractions containing ST-binding
`activity were pooled, adjusted to 0.5 M NaCl and directly
`applied to a column of wheat-germ lectin coupled to Sephar-
`ose 6B. Unbound proteins were removed by washing with
`the buffer used for dialysis containing 0.5 M NaC} and bound
`proteins were eluted by incorporating 0.5M N-acetylglu-
`cosamine in the buffer. Approximately 35% of the ST-bind-
`ing activity could be recovered in the eluted fractions. Sam-
`ples were subjected to electrophoresis and silver staining
`[26]. Cross-linking of the purified receptor preparations and
`guanylyl cyclase activity were determined as described
`above.
`
`MSN Exhibit 1032 - Page 3 of 10
`MSNv. Bausch - IPR2023-00016
`
`

`

`0.3
`
`0.2
`
`1
`
`0.
`
`E
`E
`g
`
`60
`
`40
`
`z=a
`w
`=
`=
`
`c:
`
`uv
`a 20
`
`730
`
`CG
`
`4
`
`8
`
`12
`
`16
`
`20
`
`24
`
`Time (min )
`Fig. 1. Reverse-phase HPLC profile of purified ST Y72F peptide.
`The peptide was purified from the culture supernatants of the strain
`overexpressing the ST Y72F peptide and chromatographed for a
`second time using the gradient described in the Materials and Meth-
`ods section.
`
`RESULTS
`
`Production and characterization of mutant ST peptide
`for radioligand-binding studies
`The ST, form of the toxin has two tyrosine residues
`which can incorporate iodine during preparation of a radio-
`ligand; the presence of an iodine atom in the C-terminal tyro-
`sine residue prevents binding of the radioligand to intestinal
`cells in the porcine heat-stable enterotoxin form (ST,) of the
`toxin [27]. We therefore chose to change the tyrosine residue
`at position 19 of ST, to phenylalanine, thereby retaining the
`hydrophobic nature of the C-terminus but preventing the
`incorporation of iodine into the C-terminal residue during
`radioiodination. Incorporation of iodine at position 5 of ST,
`has been shown not to affect the biological activity of the
`toxin [13].
`The mutant ST peptide, ST Y72F, was purified from the
`culture medium of the overexpressing strain [16], and the
`purity of the peptide was confirmed by reverse-phase HPLC
`(Fig. 1). When similar amounts of purified ST, and ST Y72F
`were applied to the T84 monolayer, a comparable activation
`of guanylyl cyclase was observed, since intracellular concen-
`trations of cGMP were similar at different concentrations of
`the toxin (Fig. 2). This confirmed the equipotency of ST, and
`ST Y72Fin the T84 cell line, and their near identical interac-
`tion with the receptor on T84 cells. The in vivo activity of
`ST Y72F was also confirmed by the suckling mouse assay
`(data not shown), and 10 ng peptide induced fluid accumula-
`tion in the intestine of the suckling mouse, which was a con-
`centration identical to that observed for ST,, [19].
`
`Binding of '*I-labelled ST Y72F to T84 membranes
`
`[ST] (uM)
`Fig. 2. Activation of guanylyl cyclase following application of ST,
`and ST Y72F to T84 monolayers. Purified ST, and ST Y72F were
`applied to T84 cells at the concentrations indicated and the intracel-
`lular concentrations of cGMP were monitored by radioimmunoassay
`as described earlier [19].
`
`Table 1. Activation of guanylyl cyclase in T84 membranes. Pep-
`tides were added to T84 membranes and cGMP was measured by
`radioimmunoassay. The values represent the mean + SE of duplicate
`experiments. ANF,atrial natriuretic factor.
`
`Conditions
`
`Guanylyl cyclase activity
`
`T84 membranes(basal)
`+ST, (1 uM)
`+ ANF(1 1M)
`+ST,, (1 WM) + ANF (1 pM)
`
`pmol cGMP/min/mg protein
`7.9413
`14.9 + 2.6
`6.6+12
`13.2 + 1.7
`
`Table 2. Specificity of binding of '*I-labelled ST Y72F analog.
`T84 membranes were incubated with '*I-labelled ST Y72F (0.1 nM)
`for 1 h at 37°C in the absence or presence of peptides as indicated.
`Samples were filtered and the radioactivity bound to individual fil-
`ters was measured. The values represent the mean + SE ofduplicate
`experiments. ANF,atrial natriuretic factor.
`
`Displacing ligand
`
`None
`ST, (0.2 g/ml)
`ST Y72F (0.2 pg/ml)
`ANF(0.2 j1g/ml)
`
`Amount of bound
`25]labelled ST Y72F
`
`cpm/20 pg protein
`8604 + 260
`1152 + 146
`1063 + 216
`8312 + 320
`
`Membranes were prepared from monolayer cultures of
`T84 cells. On addition of ST, or ST Y72F to the membrane
`preparations of T84 cells, the accumulation of cGMP through
`activation of membrane-bound guanylyl cyclase was ob-
`served (Table 1). Atrial natriuretic factor was unable to in-
`duce cGMP accumulation. These membrane preparations
`were used to monitor the binding of ‘*I-labelled ST Y72F to
`the receptor (Table 2). Specific binding was detected which
`could be efficiently displaced by 100 nM ofeither ST,, or ST
`Y72F, but not atrial natriuretic factor, confirming the earlier
`
`observation [19] that there was no interaction betweenatrial
`natriuretic factor and the ST Y72F receptor.
`Scatchard analysis of the equilibrium binding data of '**I-
`labelled ST Y72F to T84 membranes (Fig. 3) indicated that
`a single class of binding sites of affinity 0.37 nM (+0.03)
`was present on T84 cells at concentrations of 200 fmol/mg
`membrane protein. A similar affinity was detected when
`binding of ’*I-labelled ST Y72F to T84 monolayers was
`studied, indicating no gross changesin affinity during prepa-
`ration of the membranes (data not shown.) Using a truncated
`
`MSN Exhibit 1032 - Page 4 of 10
`MSNv. Bausch - IPR2023-00016
`
`O ST,
`ST Y72F
`
`300
`
`200
`
`100
`
`
`
`cGMP(pmol/10®
`
`celts)
`
`

`

`
`
`
`
`[*1-tabeltedSTY72F]boundlM)
`
`200
`1890
`160
`140
`120
`100
`a0
`
`40
`20
`
`8.0
`5.5
`
`x10°
`
`45
`4.0
`35
`2.0
`2.5
`20
`+5
`to
`
`
`
`(STY72F]tree os
`
`(STY72F]bound
`
`00
`
`00
`
`50
`
`100
`
`150
`
`200
`
`[STY 72F]youna ( #M)
`Fig. 3. Equilibrium binding of ST Y72F to T84 membranes. (A)
`1257_labelled ST Y72F (0.1 nM) was incubated with 50 ug T84 mem-
`brane protein at 37°C for the times indicated, the suspensions were
`filtered and the radioactivity of the filters was measured. Non-spe-
`cific binding was determined at each point by incubation in the
`presence of 100 nM ST,,. The values represent the mean oftriplicate
`determinations in two independent experiments.
`(B) Scatchard
`analysis of the equilibrium binding data. The data presented in
`Fig. 3A were subjected to an analysis using the LUNDON1 pro-
`gramme to determine the K, and the B,,,, values. The K, was found
`to be 0.3 nM and B,,,, was 200 fmol/mg protein.
`
`analog of ST [29], the cloned human receptor showed a Ky
`of 0.1 nM,indicating that the radioligand we have used for
`our studies shows properties similar to ST,. We were unable
`to detect either the presence of a low-affinity binding site
`coupled to the activation of guanylyl cyclase, as has been
`described in rat intestinal membranes, or a second class of
`high-affinity binding sites, as has been reported forrat intes-
`tinal membranesin the presence of NaCl [30].
`Competition binding analysis was performed using equal
`concentrations of ST,and ST Y72F to inhibit the binding of
`'25].labelled ST Y72F to T84 membranes (Fig. 4). The IC.,
`value of ST, (the concentration giving half-maximal binding)
`was similar to ST Y72F indicating that the binding affinities
`of ST, and ST Y72F were not significantly different.
`
`Correlation of ST binding and guanylyl! cyclase activation
`
`to T84
`Application of varying concentrations of ST,
`membranes exhibited a dose-dependent increase in cGMP
`production which correlated with an increase in binding of
`ST to the membranes (Fig. 5). Thus, half-maximal binding
`and half-maximal activation of guanylyl cyclase occurred at
`
`731
`
`bound(%total) a
`
`10
`
`100
`
`1
`
`0.0
`
`02
`
`04
`06
`08
`10
`["i-labelled STY72F},,..( 1M)
`
`12
`
`Leb
`
`[ST](nM)
`
`Fig. 4. Inhibition of binding of '**I-labelled ST Y72F by ST,, and
`ST Y72F. Purified ST,, and ST Y72Fat the concentrations indicated
`were incubated with 0.1 nM ‘*I-labelled ST Y72F and 50 pg T84
`membrane protein for 1h at 37°C, Samples were filtered and the
`radioactivity of the filters was measured. The values represent the
`mean of duplicate determinations of two independent experiments.
`ST, (@); ST Y72F (A).
`

`2
`8
`yO
`Mm
`c
`oO
`BE
`oO
`2
`s
`r
`e
`
`20
`
`1
`
`0
`[ST] (nM)
`
`‘s
`6o =
`‘Oo
`50 3
`we
`.
`o
`90 &
`a.
`205
`oO
`Pomel
`g
`
`0
`
`100
`
`Fig. 5. Correlation of ST binding and guanylyl cyclase activation.
`Increasing concentrations of ST, were added to 50 pg of T84 mem-
`brane protein and guanylyl cyclase activity was determined as de-
`scribed in the Materials and Methodssection: In a parallel experi-
`ment, 0.1 nM ‘*I-labelled ST Y72F was incubated with varying con-
`centrations of unlabelled ST,, and the amount of ST,, bound to the
`membranes at each concentration was determined from the binding
`data obtained. The values represent the mean of duplicate determin-
`ations of two independent experiments.
`
`5 nM ST,,indicating that the binding of ST, was functionally
`coupled to the activation of guanylyl cyclase.
`The binding of ST to the human receptor showed a
`marked pH dependency in that the binding of '*I-labelled
`ST Y72F was doubled at pH 5 (Table 3). Further analysis
`revealed no change in the affinity of the receptor to the li-
`gand, but a doubling in the capacity of the binding sites.
`Similar observations were reported earlier using monolayer
`cultures of T84 cells [28], and the cloned human receptor
`expressed in 293 cells [29]. We could show howeverthat the
`increase in binding at pH 5.0 was correlated with an increase
`in cGMPproduction by T84 membranes, indicating a func-
`tional coupling of binding and activation at
`low pH
`(Table 3). A higher basal activity of guanylyl cyclase was
`observed following prior incubation at lower pH, but there
`was a concomitant increase in activation of guanylyl cyclase
`
`MSNExhibit 1032 - Page 5 of 10
`MSNv. Bausch - IPR2023-00016
`
`

`

`10°x"1-labelledSTY72Fbound(cpm) 5 0
`
`
`
`In(Be/Be-Bt)
`
`20
`
`30
`
`40
`
`$o
`
`60
`
`70
`
`
`50
`
`80
`
`Time (min }
`
`Time (min)
`
`Fig.6. Association kinetics of the binding of ™I-labelled ST
`Y72¥F to T84 membranes. (A) '”I-labelled ST Y72F (0.1 nM) was
`incubated at 37°C with T84 membranesfor the times and pH values
`indicated. Samples werefiltered and the radioactivity boundto indi-
`vidual filters was measured. Non-specific binding was determined
`in the presence of 100 nM unlabelled ST,, and has been subtracted
`from the values shown. The data represent the mean oftriplicate
`determinations. (B) A semi-logarithmic representation of the pseu-
`do-first-order association reaction at pH 7.5, where B, and B, repre-
`sent ligand bound at equilibrium and at time ¢, respectively.
`
`732
`
`Table 3. pH dependenceof the binding and activation of guany-
`lyl cyclase by ST. Equilibrium binding of '*I-labelied ST Y72F to
`T84 membranes was performed at the pH indicated and the data
`were subjected to Scatchard Analysis using the LUNDON1 pro-
`gramme. Guanylyl cyclase assays were conducted in the absence of
`peptide to monitor the basal activity present in T84 membranes, or
`in the presence of 1M ST,. The values represent the mean of
`duplicate experiments.
`
`pH
`
`Amount of
`ST bound
`
`fmol/mg protein
`
`15
`5.0
`
`200
`450
`
`Ks
`
`nM
`
`0.31
`0.4
`
`cGMP
`
`—ST,
`
`+ST,,
`
`pmol/min/mg protein —
`
`8.8
`50
`
`29
`110
`
`by ST, corresponding to an enhanced binding of the peptide
`at pH 5.0.
`At a pH greater than 10.0, ST failed to bind to the recep-
`tor in T84 membranes, but this lack of binding was not due
`to inactivation of the receptor, since binding was effectively
`and quantitatively restored on lowering the pH to 7.5 during
`the binding assay (data not shown).
`The association and dissociation kinetics of the binding
`of ST Y72F to T84 membranes are shown in Figs 6 and 7.
`A calculation of the K, from the kinetic data, indicated a
`value of 0.4 nM in close agreement with that estimated from
`a Scatchard analysis. Dissociation of the ligand at pH 5.0
`was slower than that at pH 7.5, despite the similarity in bind-
`ing affinity to that observed at pH 7.5 as estimated from a
`Scatchard analysis (Fig. 3).
`Dissociation of bound ***I-labelled ST Y72F was rapid
`at pH 10.7 (Fig. 7), and binding was eventually abolished,
`suggesting that any local changes in pH in the intestine may
`regulate ST-induced diarrheal responses. A study does indeed
`indicate an increase in alkalinity of the intestinal mucosae
`following application of ST, and this may play a role in the
`transient nature of ST-mediated diarrhoea [31].
`
`Solubilization and affinity cross-linking of radiolabelled
`ST Y72F to the receptor on T84 cells
`
`Affinity cross-linking of ST Y72F
`to the solubilised receptor
`
`Optimum solubilization of the ST receptor from T84
`membranes was achieved using 0.3% Lubrol and 0.5M
`The molecular mass of the ST receptor in T84 cells was
`NaCl. This combination of a non-ionic detergent and NaC]
`determined by affinity cross-linking using the cross-linker
`dithio-bis(succinimidy] propionate). Cross-linking of the so-
`was recommended previously for efficient solubilization of
`lubilised receptor using 0.10M ’J-labelled ST Y72F and
`the rat intestinal membrane receptor [32] and, in the case of
`2mM_dithio-bis(succinimidyl propionate) followed by SDS/
`the humanreceptor in T84 cells, the presence of 0.5 M NaCl
`during solubilization was essential. The affinity of the recep-
`PAGEandautoradiography (Fig. 8) revealed a single radio-
`tor was not significantly changed on solubilisation (Table 4),
`active band of M, 160000, which was abolished when cross-
`and approximately 70% of the receptor could be solubilised
`linking was performed in the presence of 100 nM ST,,. The
`under these conditions. Some amount of ST-binding activity
`M,of the cross-linked protein was similar to the calculated
`was howeverassociated with the insoluble cytoskeletal frac-
`M, based on the predicted sequence of the recombinantpro-
`tion, which also retained guanylyl cyclase activity.
`tein {12, 13]. Treatment of the cross-linked sample with
`Guanylyl cyclase activity was, markedly enhanced during
`100 mM 2-mercaptoethanol resulted in the disappearance of
`solubilisation, and this detergent-induced activation has been
`the cross-linked band on autoradiography, since the thiol-
`reported for all membrane-associated guanylyl cyclases to
`cleavable cross-linker dissociates the ligand from the recep-
`date [33, 34]. On addition of 100 nM ST, to the solubilised
`tor under reducing conditions. No low-M, forms ofthe recep-
`preparation, an increase over the basal activity was observed
`tor were observed after SDS/PAGE,in contrast to the variety
`especially in freshly solubilised preparations (Table 4), but
`of low-molecular-mass receptors that were identified in the
`rat intestinal membranes by cross-linking [35], as well as
`this property was lost on storage (data not shown).
`
`MSN Exhibit 1032 - Page 6 of 10
`MSNv. Bausch - IPR2023-00016
`
`

`

`Ww
`
`30
`
`50
`
`90
`70
`Time (min)
`
`no
`
`130
`
`150
`
`£0D
`&2
`zan
`2
`
`0.00
`
`-0.50
`
`-0.10
`

`ao~
`ww - 90.55
`oO
`£&
`
` an
`- 925 - 0.30
`
`0
`
`10
`
`20
`
`30
`
`40
`
`50
`
`60
`
`70
`
`80
`
`90
`
`100
`
`v0
`
`120
`
`Time (min)
`
`Fig. 7. Dissociation kinetics of ’*I-labelled ST Y72F binding to
`T84 membranes.
`'**I-labelled ST Y72F (0.1 nM) was incubated
`with T84 membranes for 1 h at 37°C at the pH indicated and the
`sample was centrifuged. Membranepellets were suspended in buffer
`at the pH used during binding, but without labelled ST Y72F and
`aliquots were removed at the times indicated and filtered. Values
`represent the mean oftriplicate determinations of two independent
`experiments. (B) A semi-logarithmic representation ofthe first-order
`dissociation reac

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket